New Findings in Molecular and Structural Properties of IL-23 Inhibitors: A Breakthrough in Psoriasis TreatmentÂ
Biologics that inhibit the pro-inflammatory cytokine IL-23 have long been
Biologics that inhibit the pro-inflammatory cytokine IL-23 have long been
As headlines report the recent revelation of benzene, a known
Monumental regulatory approvals are taking dermatologic care to new levels
Here is a brief recap of some of the most notable advances and the U.S. Food and Drug Administration (FDA) approvals in 2022.
It is widely accepted and recognized that psychodermatologic issues are commonly encountered in dermatological practices.
The U.S. Food and Drug Administration (FDA) has approved the
Alopecia is the abnormal loss of hair on the scalp,
In the past decade, awareness has been raised around improving
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
LiVDerm / South Beach Symposium
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431
Copyright © 2024, LiVDerm. All Rights Reserved.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.